95715-86-9 (i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷,3-tert-butyl 4-methyl (4R)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate)

CAS号:
95715-86-9
中文名称:
i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷
英文名称:
3-tert-butyl 4-methyl (4R)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate
安全信息:
分子式:
C12H21NO5
分子量:
259.298844099045

i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷(95715-86-9)名称与标识符

名称

中文别名:
(R)-(+)-3-BOC-2-1,2-二甲基-4-恶唑烷羧酸甲酯;(R)-(+)-3-Boc-2,2-二甲基-4-噁唑烷羧酸甲酯;(R)-(+)-3-Boc-2,2-二甲基恶唑啉-4-甲酸甲酯;(R)-(+)-3-叔丁氧羰基-2,2-二甲基-4-噁唑烷羧酸甲酯;(R)-N-Boc-2,2-二甲基噁唑烷-4-甲酸甲酯;i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷;(R)-(+)-3-(叔丁氧羰基)-2,2-二甲基-4-噁唑啉羧酸甲酯;(R)-(+)-3-Boc-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷;(R)-(+)-2,2-二甲基恶唑烷-3,4-二甲酸3-叔丁基4-甲酯;(R)-(+)-3-(叔-丁氧羰基)-2,2-二甲基-4-恶唑烷羧酸甲酯;(R)-(+)-3-叔丁氧羰基-2,2-二甲基-4-噁唑烷羧酸甲;
英文别名:
METHYL (R)-(+)-3-BOC-2,2-DIMETHYL-4-OXAZOLIDINECARBOXYLATE;METHYL (R)-(+)-3-(TERT-BUTOXYCARBONYL)-2,2-DIMETHYL-4-OXAZOLIDINECARBOXYLATE;(R)-(+)-3-(tert-Butoxycarbonyl)-4-methoxycarbonyl-2,2-dimethyl-1,3-oxazolidine;(R)-(+)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-oxazolidinecarboxylic Acid Methyl Ester;(R)-3-tert-Butyl 4-methyl 2,2-dimethyloxazolidine-3,4-dicarboxylate;3,4-Oxazolidinedicarboxylicacid, 2,2-dimethyl-, 3-(1,1-dimethylethyl) 4-methyl ester, (4R)-;Methyl (R)-N-Boc-2,2-dimethyloxazolidine-4-carboxylate;NULL;(R)-(+)-3-Boc-4-methoxycarbonyl-2,2-dimethyl-1,3-oxazolidine;3-tert-Butyl 4-Methyl (R)-(+)-2,2-Dimethyloxazolidine-3,4-dicarboxylate;(R)-(+)-2,2-Dimethyloxazolidine-3,4-dicarboxylic Acid 3-tert-Butyl 4-Methyl Ester;3,4-Oxazolidinedicarboxylic acid, 2,2-dimethyl-, 3-(1,1-dimethylethyl) 4-methyl ester, (R)- (ZCI);(R)-2,2-Dimethyloxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester;(R)-Methyl-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-oxazolidinecarboxylate;3-O-tert-Butyl 4-O-methyl (4R)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate;3-tert-butyl 4-methyl (4R)-2,2-dimethyl-1,3-oxazolidine-3,4-dicarboxylate;B5352;95715-86-9;DTXSID60350836;CS-D1220;3,4-Oxazolidinedicarboxylicacid,2,2-dimethyl-,3-(1,1-dimethylethyl)4-methyl ester,(4R)-;MFCD00674041;SCHEMBL121419;EN300-651263;(R)-(-)-3-BOC-4-methoxycarbonyl-2,2-dimethyl-1,3-oxazolidine;PS-7373;BP-12795;Methyl (R)-(+)-3-Boc-2,2-dimethyl-4-oxazolidinecarboxylate, 98%;Methyl(R)-N-Boc-2,2-dimethyloxazolidine-4-carboxylate;Methyl (4R)-(+)-2,2-dimethyl-1,3-oxazolidine-4-carboxylate, N-BOC protected;(4R)-2,2-Dimethyl-3,4-oxazolidinedicarboxylic Acid 3-(1,1-Dimethylethyl) 4-Methyl Ester; (R)-2,2-Dimethyloxazolidine-3,4-dicarboxylic Acid 3-tert-Butyl Ester 4-Methyl Ester;;O3-tert-Butyl O4-methyl (4R)-2,2-dimethyloxazolidine-3,4-dicarboxylate;3-(1,1-Dimethylethyl)-4-methyl-(r)-2,2-dimethyl-3,4-oxazolidinedicarboxylate;N88SYW3697;ZNBUXTFASGDVCL-MRVPVSSYSA-N;3,4-Oxazolidinedicarboxylic acid, 2,2-dimethyl-, 3-(1,1-dimethylethyl) 4-methyl ester, (4R)-;Methyl 3-tert-butoxycarbonyl-2,2-dimethyloxazolidine-4-(R)-carboxylate;AKOS015893990;

标识符

MDL:
MFCD00674041
InChIKey:
ZNBUXTFASGDVCL-MRVPVSSYSA-N
Inchi:
1S/C12H21NO5/c1-11(2,3)18-10(15)13-8(9(14)16-6)7-17-12(13,4)5/h8H,7H2,1-6H3/t8-/m1/s1
SMILES:
C(N1C(C)(C)OC[C@@H]1C(=O)OC)(=O)OC(C)(C)C

i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷(95715-86-9)物化性质

实验特性

  • LogP : 1.46930
  • PSA : 65.07000
  • 折射率 : n20/D 1.444(lit.)
  • 沸点 : 102°C/2mmHg(lit.)
  • 闪点 : 华氏:199.4 °F
    摄氏:93 °C
  • 溶解度 : 微溶 (3.9 g/L) (25 ºC),
  • 颜色与性状 : 液体
  • 光学活性 : [α]20/D +54°, c = 1.3 in chloroform
  • 密度 : 1.082 g/mL at 25 °C(lit.)

计算特性

  • 精确分子量 : 259.14197277g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 5
  • 同位素质量 : 259.14197277g/mol
  • 重原子数量 : 18
  • 复杂度 : 345
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 1
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.4
  • 拓扑分子极性表面积 : 65.1Ų

i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷(95715-86-9)推荐厂家 更多厂家(17)

i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷(95715-86-9)合成路线

合成路线:1 步
反应条件:
参考文献:
Transformation of D-serine to highly functionalized cyclohexenecarboxylates in study of oseltamivir synthesis
Lai, Joshua; Fang, Jim-Min, Journal of the Chinese Chemical Society (Weinheim, 2012, 59(3), 426-435
合成路线:1 步
反应条件:
参考文献:
Novel Peptidomimetic Cysteine Protease Inhibitors as Potential Antimalarial Agents
Micale, Nicola; Kozikowski, Alan P.; Ettari, Roberta; Grasso, Silvana; Zappala, Maria; et al, Journal of Medicinal Chemistry, 2006, 49(11), 3064-3067
合成路线:1 步
反应条件:
参考文献:
Preparation of (R)-4-formyl-2,2-dimethyl-3-oxazoline carboxylic acid tert butyl ester
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Docking study, synthesis and SAH-hydrolase inhibitory activity of L-adeninylalanine and related analogues
Floquet, Nicolas; Leroy, Samuel; Muzard, Murielle; Guillerm, Georges; Behr, Jean-Bernard, Letters in Drug Design & Discovery, 2005, 2(8), 579-583
合成路线:1 步
反应条件:
参考文献:
Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position
Qian, Wenjian; Park, Jung-Eun; Liu, Fa; Lee, Kyung S.; Burke, Terrence R., Bioorganic & Medicinal Chemistry, 2013, 21(14), 3996-4003
合成路线:1 步
反应条件:
参考文献:
Generating stereodiversity: Diastereoselective fluorination and highly diastereoselective epimerization of α-amino acid building blocks
Wei, Wei; Khangarot, Rama Kanwar; Stahl, Lothar ; Veresmortean, Cristina; Pradhan, Padmanava; et al, Organic Letters, 2018, 20(12), 3574-3578
合成路线:1 步
反应条件:
参考文献:
In Search of Small Molecules That Selectively Inhibit MBOAT4
Murzinski, Emily S.; Saha, Ishika ; Ding, Hui; Strugatsky, David ; Hollibaugh, Ryan A. ; et al, Molecules, 2021, 26(24),
合成路线:1 步
反应条件:
参考文献:
Docking model of the nicotinic acetylcholine receptor and nitromethylene neonicotinoid derivatives with a longer chiral substituent and their biological activities
Nagaoka, Hikaru; Nishiwaki, Hisashi; Kubo, Takuya; Akamatsu, Miki; Yamauchi, Satoshi; et al, Bioorganic & Medicinal Chemistry, 2015, 23(4), 759-769
合成路线:1 步
参考文献:
Total Synthesis of (+)-Galactostatin. An Illustration of the Utility of the Thiazole-Aldehyde Synthesis
Dondoni, Alessandro; Perrone, Daniela, Journal of Organic Chemistry, 1995, 60(15), 4749-54
合成路线:1 步
反应条件:
参考文献:
Preparation of heterocyclic compounds as antibacterial compounds
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Methods and intermediates for synthesizing SK1-I
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of isoindoline derivatives and their use in treating neurodegenerative diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of macrocyclic broad spectrum antibiotics as bacterial type 1 signal peptidase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Orthogonally protected glycerols and 2-aminodiols: useful building blocks in heterocyclic chemistry
Ollivier, Anthony; Goubert, Marlene; Tursun, Ahmatjan; Canet, Isabelle; Sinibaldi, Marie-Eve, ARKIVOC (Gainesville, 2010, (9), 108-126
合成路线:1 步
反应条件:
参考文献:
Preparation of oxodiazabicyclooctenyl hydrogen sulfate derivatives for use as beta-lactamase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
4,4-Difluorinated analogues of -arginine and N G-hydroxy--arginine as mechanistic probes for nitric oxide synthase
Martin, Nathaniel I.; Woodward, Joshua J.; Winter, Michael B.; Marletta, Michael A., Bioorganic & Medicinal Chemistry Letters, 2009, 19(6), 1758-1762
合成路线:1 步
反应条件:
参考文献:
Synthesis of fluorescent lactosylceramide stereoisomers
Liu, Yidong; Bittman, Robert, Chemistry and Physics of Lipids, 2006, 142(1-2), 58-69
合成路线:1 步
反应条件:
参考文献:
Design, synthesis and structure-activity relationship studies of a novel focused library of 2,3,4-substituted oxazolidines with antiproliferative activity against cancer cell lines
Andrade, Saulo F.; Oliveira, Barbara G.; Pereira, Larissa C.; Ramos, Jonas P.; Joaquim, Angelica R.; et al, European Journal of Medicinal Chemistry, 2017, 138, 13-25
合成路线:1 步
反应条件:
参考文献:
Synthesis of a novel series of 2,3,4-trisubstituted oxazolidines designed by isosteric replacement or rigidification of the structure and cytotoxic evaluation
Andrade, Saulo F.; Teixeira, Claudia S.; Ramos, Jonas P.; Lopes, Marcela S.; Padua, Rodrigo M.; et al, MedChemComm, 2014, 5(11), 1693-1699
合成路线:1 步
反应条件:
参考文献:
Facile synthesis of L-3,4-didehydrovaline constituting an antibiotic, phomopsin A
Yonezawa, Yasuchika; Shimizu, Kanetaka; Yoon, Kwan-Sik; Shin, Chung-Gi, Synthesis, 2000, (5), 634-636

i>)-(+)-3-(叔丁氧羰基)-4-甲氧羰基-2,2-二甲基-1,3-恶唑烷(95715-86-9)参考资料

Reaxys RN:
4694109
Beilstein:
R188854
PubChem CID: